PFA Newspaper Publication w.r.t Audited Financial Results for the Quarter and Year ended 31st March, 2026
Awaiting price reaction for this filing.
MPS Pharmaa Limited (CIN: L74899HR1994PLC038300) published its audited financial results for Q4 and full year ended 31 March 2026 in Financial Express and Jansatta newspapers on 29 May 2026. For Q4 FY26, the company reported total income of Rs 4.77 Lakh, a loss before tax of Rs 105.79 Lakh, and a loss after tax of Rs 102 Lakh — significantly worse than Q4 FY25 which had a loss of Rs 22.92 Lakh before tax. For the full year FY26, the company posted total income of Rs 4.77 Lakh against Rs 3.56 Lakh in FY25. The net loss before tax for FY26 was Rs 105.79 Lakh (vs Rs 86.39 Lakh in FY25), and after tax was Rs 102 Lakh (vs Rs 89.79 Lakh in FY25). Earnings per share remained deeply negative at Rs (0.53) for FY26 and Rs (0.15) for Q4. Reserves stood at negative Rs 1,904.29 Lakh, indicating total erosion of equity. The company also published a SEBI notice regarding a special window for dematerialisation of physical shares open till 4 February 2027.
The company is in significant financial distress with widening losses, negative reserves, and negative EPS. Shareholders face substantial risk as accumulated losses have wiped out the equity base. The stock (BSE: 531686) is likely to remain under pressure given deteriorating financials.